|
|
||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Renal-Electrolyte Division, Department of Medicine; 2Center for Research in Reproductive Physiology, Department of Cell Biology and Physiology, and 3Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine; 4Program in Membrane Biology and Nephrology Division, Center for Systems Biology, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts
Submitted 11 November 2007 ; accepted in final form 20 December 2007
| ABSTRACT |
|---|
|
|
|---|
vas deferens; Epac; protein kinase inhibitor
The V-ATPase is expressed ubiquitously in eukaryotes, where it can be found in organelles requiring luminal acidification, such as lysosomes, the Golgi apparatus, endosomes, and secretory vesicles (45). In addition to clear cells, the V-ATPase is expressed in the plasma membrane of some specialized cells, such as kidney intercalated cells, osteoclasts, and CA-rich
-cells of the turtle bladder (10). Proton secretion in these specialized acid-secreting cells is actively regulated by environmental cues that include CO2, bicarbonate, and hormonal stimuli (45).
At the cellular level, V-ATPase-mediated proton secretion can be regulated by several mechanisms, including: 1) V-ATPase isoform subunit expression, 2) reversible dissociation of the membrane-associated V0 and the catalytic V1 sectors of the V-ATPase, 3) modulation of the coupling between ATP hydrolysis and proton pumping, and 4) modulation of recycling and targeting of V-ATPase-containing vesicles (reviewed in Ref. 5). Indeed, an increase in V-ATPase surface expression and in apical surface area (including microvilli) in these specialized cells correlates with an increase in proton secretion (reviewed in Ref. 40). We have shown previously that, as in other specialized V-ATPase-expressing cells, V-ATPase-containing vesicles in epididymal clear cells recycle between intracellular vesicles and the apical plasma membrane, which indicates that these cells also utilize this regulatory mechanism to control their rate of proton secretion (1, 34).
Extracellular pH changes have been implicated in exocytosis of channels and organelle trafficking (20, 25, 27). It has been shown previously that cAMP stimulates proton secretion in a number of epithelial cell types involved in acidification, including the kidney medullary collecting duct cells (13, 18, 21, 22). In addition cAMP is involved in regulating the exocytosis of many actively recycling membrane transporter, such as aquaporin 2 (AQP2), aquaporin 8 (AQP8), the cystic fibrosis transmembrane conductance regulator (CFTR), and the glucose transporter (GLUT4) (9, 17, 24, 26).
In the male reproductive tract, we have shown previously that V-ATPase accumulates in the plasma membrane of clear cells in response to cAMP, alkaline luminal pH, and to increases in luminal bicarbonate concentration (34). In addition, we demonstrated that bicarbonate-regulated soluble adenylyl cyclase (sAC), a chemosensor that induces a bicarbonate-dependent elevation of intracellular cAMP, mediates the pH-dependent V-ATPase recycling in epididymal clear cells (34). In the same study, a cell-permeant analog of cAMP by itself induced the apical translocation of V-ATPase in these cells even at acidic luminal pH (34).
PKA is a major mediator that transmits an increase in cAMP to effector and target proteins in cells. Phosphorylation of proteins by PKA is thought to be a major step in cAMP-mediated exocytosis (reviewed in Ref. 38). However, an alternative cAMP-dependent signaling pathway that is independent of PKA has also been identified and involves the exchange protein directly activated by cAMP (Epac). Epacs are guanine nucleotide exchange factors for the Ras-like small GTPase Rap1, and they are insensitive to PKA inhibitors and function even in the absence of an active PKA pathway (14).
In the present study, we investigated the role of Epac and PKA in vivo on the regulation of alkaline pH-induced and cAMP-mediated V-ATPase redistribution in rat epididymal clear cells. Our data suggest that PKA activation is both necessary and sufficient to induce V-ATPase accumulation in the apical membrane of epididymal clear cells.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Tissue fixation and immunofluorescence staining. Animal protocols were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh School of Medicine. Adult male Sprague-Dawley rats were anesthetized with pentobarbital sodium (65 mg/kg body wt ip) and perfused via the left ventricle with PBS (pH 7.4), followed by a phosphate-buffered solution containing 4% paraformaldehyde, 10 mM sodium periodate, 70 mM lysine, and 5% sucrose (PLP). They were processed for immunofluorescence as described previously (6, 7, 33, 34). Briefly, the epididymis and vas deferens (VD) were harvested and further fixed by immersion in PLP overnight and cryoprotected in a solution of 30% sucrose in PBS overnight at 4°C. These tissues were embedded in OT Compound (Tissue TEK, Sakura Finetek, Torrance, CA) and mounted on a cutting block before being frozen in a Reichert Frigocut microtome. Sections were picked up on Superfrost Plus slides (Fisher, Pittsburgh, PA). Immunofluorescence staining was performed on 4-µm cryostat sections after SDS antigen retrieval as previously described (11). Slides were washed in PBS followed by incubation with a blocking solution containing 1% bovine serum albumin in PBS-0.02% sodium azide for 15 min. Slides were then incubated with an anti-Epac antibody (raised in goat, 1:50 dilution) that recognizes the COOH-terminus of both isoforms of Epac1 and Epac2, followed by an antibody against the E subunit of the V-ATPase (raised in rabbit, 1:60 dilution) for 75 min at room temperature (both antibodies from Santa Cruz Biotechnology, Santa Cruz, CA). Sections were then washed twice for 5 min in high-salt PBS (2.7% NaCl) and once in PBS and then incubated for 1 h with donkey anti-goat IgG coupled to FITC and donkey anti-rabbit IgG coupled to CY3 (Jackson Immunologicals, West Grove, PA). After further washes in PBS, the slides were coverslipped after being mounted with Vectashield (Vector Labs, Burlingame, CA). The Epac immunizing peptide used to produce this antibody was employed for peptide inhibition controls using methods previously described (33).
In vivo perfusion of the VD and distal cauda epididymidis and immunofluorescence staining.
We have demonstrated previously that activation of V-ATPase-dependent proton secretion in clear cells is proportional to the apical membrane V-ATPase accumulation, which results in a marked elongation of microvilli that contain a higher density of V-ATPase molecules (1, 31). In the present study, as a read-out for the V-ATPase apical accumulation in clear cells, we measured the effects of cAMP downstream effectors on the extension of V-ATPase-labeled microvilli. Adult male Sprague-Dawley rats were anesthetized as described above. An incision was made in the scrotum that exposed the VD and epididymal cauda. The distal VD lumen was cannulated using a microcannula (0.4 mm OD, 0.2 mm ID; Fine Science Tools, Foster City, CA). An additional incision was then made in the distal epididymal cauda as previously described (34). We estimate that in most preparations we perfused 4–5 cm of distal epididymal cauda/VD, of which
1 cm was proximal VD. Retrograde perfusion was performed from the VD into the distal epididymal cauda and the perfusate exited via the incision made in the distal epididymal cauda. The perfusion rate was 45 µl/min, using a syringe pump (model 341B, Fisher). The lumen was initially washed free of sperm with PBS adjusted to pH 6.5, as indicated in RESULTS. HRP was added to the perfusate at a concentration of 5 mg/ml to detect endocytosis in the absence or presence of inhibitors and agonists. At the end of the experimental period, the luminal solution was changed to HRP-free ice-cold PBS for 6–9 min (in the continued presence of agonists or inhibitors, as applicable) to wash the lumen free of HRP. The perfused portions of the vas deferens and cauda epididymidis were harvested and fixed by immersion in PLP for 5 h at room temperature or overnight at 4°C. Tissues were then washed in PBS, pH 7.4, and stored in PBS containing 0.02% sodium azide, cryoprotected, embedded, and sectioned as described above. Double immunofluorescence staining was performed using our immunopurified chicken antibody (1:60 dilution) (34) or a rabbit antibody (Santa Cruz, 1:60 dilution) against the E subunit of the V-ATPase combined with an anti-HRP antibody raised in goat at a concentration of 1:300 (Sigma). Washes and secondary antibodies were used as previously described (34). At least three VD and cauda epididymidis were perfused for each condition described. A minimum of 6–10 cells per tissue were examined by confocal microscopy for a total of at least 30 cells per condition. In Figs. 2, 3, 5–8, only the V-ATPase immunofluorescence staining is shown (green).
|
|
|
|
After quantification of the protein concentration using the Bradford assay (Bio-Rad, Hercules, CA), IPs were performed overnight at 4°C on each lysate sample containing 1.0 mg of total protein using either the anti-Epac antibody (0.5 µg/IP) coupled to protein A/G beads or beads alone as previously described (2). After three washes in lysis buffer, the IP samples were then eluted in Laemmli sample buffer and, along with the cell lysate samples, subjected to SDS-PAGE and immunoblotting using previously described protocols (33). Immunoblotting was performed at 1:2,500 dilution of the same anti-Epac antibody in 5% milk in TBS-Tween followed by HRP-conjugated secondary anti-goat antibody (Jackson Immunologicals) at a concentration of 1:10,000. Membranes were then stripped and reprobed with anti-Epac antibody that had been preincubated with the immunizing peptide to demonstrate anti-Epac antibody specificity.
Quantification of V-ATPase apical membrane accumulation. The level of V-ATPase accumulation in the apical membrane of clear cells of the proximal VD and epididymal cauda was quantified from confocal microscopy images as previously described, a quantification method that was validated by immunogold electron microscopy (1, 34). Briefly, confocal images were imported into Metamorph (Molecular Devices, Sunnyvale, CA), the microvilli positive for V-ATPase staining were outlined, and the area occupied by the microvilli was measured. The area measurement for each cell was normalized to the width of the cell between the tight junctions at the apical pole. At least three epididymides were perfused for each condition from different animals, and we examined a minimum of three separate immunofluorescence staining procedures for each tissue. Six to 10 cells were examined per tissue with a total of at least 30 cells per condition used for quantification. These measurements were performed for each image independently by two investigators, who were blinded as to the treatment group. Student's unpaired t-tests were performed, and differences were considered significant at P < 0.05.
| RESULTS |
|---|
|
|
|---|
|
Presence of Epac in epididymal epithelium by WB and IP.
The actions of cAMP were classically thought to be mediated almost exclusively by PKA. However, there is now a growing body of literature that indicates that cAMP also acts via Epac (15). This family of guanine nucleotide exchange factors mediates Rap activation in the presence of cAMP. We hypothesized that increases in intracellular cAMP in clear cells might also activate Epac in a PKA-independent manner. By immunofluorescence, Epac (Fig. 4, A and D) is detectable in the apical cytoplasm of clear (V-ATPase-rich) and principal cells of the epididymal epithelium (Fig. 4, A–C). No labeling was detectable in epididymis when antibody preabsorbed with the anti-Epac immunizing peptide was used (Fig. 4E). In addition, WB after IP of Epac from enriched epididymal-VD epithelial cell preparation (epithelial "sock") lysates revealed two bands at
90 and 110 kDa (Fig. 4F, left) that were not present when antibody was omitted from the IP (Fig. 4G, top) and were competed away by the immunizing peptide (Fig. 4F, right and 4G, bottom). These bands probably represent Epac1 and Epac2, which have these expected molecular weights. In Fig. 4F, the band that is detected in the WB after peptide inhibition probably represents the anti-Epac primary antibody (IgG) used in the IP as detected by the secondary antibody in the WB.
|
However, perfusion at a concentration of 100 µM 8CPT-2-O-Me-cAMP, which is known to activate PKA (15), induced a significant accumulation of V-ATPase in the apical membrane of clear cells (Fig. 6B) when compared with that of controls (Fig. 6A). This difference was confirmed by quantification of the area occupied by the apical microvilli of clear cells exposed to each condition, as described above (Fig. 6C). Preperfusion of tissues with the specific PKA inhibitor mPKI (10 µM) completely inhibited the V-ATPase apical membrane accumulation induced by 100 µM 8CPT-2-O-Me-cAMP (Fig. 7, A–C), consistent with an activating effect of 8CPT-2-O-Me-cAMP on PKA at high concentrations.
|
|
| DISCUSSION |
|---|
|
|
|---|
The 8CPT-2-O-Me-cAMP compound did not induce the apical accumulation of the V-ATPase when used at a concentration (10 µM) known to be specific for Epac (4, 15). However, when used at the higher concentration of 100 µM, a concentration that was shown to also induce PKA activation (15), accumulation of V-ATPase in apical microvilli was observed. Preperfusion with mPKI completely inhibited the effect of 100 µM 2-O-Me-cAMP on the redistribution of V-ATPase to the apical membrane, confirming that PKA was activated by this cAMP analog at high concentrations. Our results suggest that the Epac activator 8CPT-2-O-Me-cAMP is not specific for Epac at higher concentrations and thus results obtained at these higher concentrations should be interpreted with caution.
Inhibition of PKA with mPKI under baseline conditions (PBS at pH 6.5) did not significantly change the distribution of the V-ATPase in clear cells. This result indicates that PKA is involved in V-ATPase trafficking only under conditions of stimulation (e.g., with high luminal bicarbonate concentrations, alkaline luminal pH, or high intracellular cAMP levels). Because we have reported in earlier studies that the V-ATPase recycles constitutively between intracellular vesicles and the plasma membrane in clear cells, this finding implies that PKA activation is not necessary for this baseline recycling process (34). A similar finding has been reported for another recycling protein, AQP2, whose membrane accumulation is stimulated by a cAMP-PKA-mediated signaling process (9, 16, 32) but whose constitutive recycling pathway is cAMP and PKA independent (30).
We also show here that Epac is present in epididymal epithelium. Epac is an exchange protein activated by cAMP that has been implicated in several cAMP-mediated cellular events, including exocytosis, insulin secretion, cell adhesion, and cell-junction formation (4, 15). As far as the regulation of trafficking of epithelial membrane transport proteins is concerned, Epac has been shown to regulate the Ca2+ mobilization and AQP2 exocytosis in the inner medullary collecting duct (47). Although Epac in clear cells may also be activated by intracellular cAMP, our results argue against an obligatory role for Epac in the cAMP-dependent trafficking of the V-ATPase. However, because specific Epac inhibitors are not yet available, we cannot exclude the possibility that Epac may contribute to the response. Our data do suggest, however, that PKA activation by cAMP is both necessary and sufficient to induce the accumulation of V-ATPase in apical microvilli.
The downstream targets that are phosphorylated by PKA to regulate V-ATPase membrane accumulation in clear cells (e.g., the V-ATPase itself or accessory proteins involved in its trafficking) have not yet been identified. In mammalian cells, it has been reported that the B subunit of the V-ATPase from bovine brain is phosphorylated, although the role of this phosphorylation on V-ATPase activity has not been fully elucidated (31). In addition, none of the subunits of the V-ATPase have been found to be phosphorylated by PKA in mammals (42, 45). We have shown previously that the cAMP-mediated V-ATPase apical accumulation in clear cells requires the remodeling of the actin cytoskeleton (1). We have suggested that an indirect mechanism might be involved in the cAMP-induced apical accumulation of the V-ATPase, as it is in the case of other transporters (36, 37, 39, 43, 46). Recently, the C subunit of the V-ATPase has been found to be phosphorylated by PKA in insects, suggesting that this kinase may act directly to modulate V-ATPase accumulation in subcellular compartments (44). We believe that further characterization of this PKA-dependent pathway is warranted to identify novel targets for the treatment of male infertility or for the development of a male contraceptive.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Bhalla V, Oyster NM, Fitch AC, Wijngaarden MA, Neumann D, Schlattner U, Pearce D, Hallows KR. AMP-activated kinase inhibits the epithelial Na+ channel through functional regulation of the ubiquitin ligase Nedd4-2. J Biol Chem 281: 26159–26169, 2006.
3. Blomqvist SR, Vidarsson H, Soder O, Enerback S. Epididymal expression of the forkhead transcription factor Foxi1 is required for male fertility. EMBO J 25: 4131–4141, 2006.[CrossRef][Web of Science][Medline]
4. Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31: 680–686, 2006.[CrossRef][Web of Science][Medline]
5. Breton S, Brown D. New insights into the regulation of V-ATPase-dependent proton secretion. Am J Physiol Renal Physiol 292: F1–F10, 2007.
6. Breton S, Hammar K, Smith PJ, Brown D. Proton secretion in the male reproductive tract: involvement of Cl–-independent HCO3– transport. Am J Physiol Cell Physiol 275: C1134–C1142, 1998.
7. Breton S, Nsumu NN, Galli T, Sabolic I, Smith PJ, Brown D. Tetanus toxin-mediated cleavage of cellubrevin inhibits proton secretion in the male reproductive tract. Am J Physiol Renal Physiol 278: F717–F725, 2000.
8. Breton S, Smith PJ, Lui B, Brown D. Acidification of the male reproductive tract by a proton pumping (H+)-ATPase. Nat Med 2: 470–472, 1996.[CrossRef][Web of Science][Medline]
9. Brown D. The ins and outs of aquaporin-2 trafficking. Am J Physiol Renal Physiol 284: F893–F901, 2003.
10. Brown D, Breton S. Mitochondria-rich, proton-secreting epithelial cells. J Exp Biol 199: 2345–2358, 1996.[Abstract]
11. Brown D, Lydon J, McLaughlin M, Stuart-Tilley A, Tyszkowski R, Alper S. Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS). Histochem Cell Biol 105: 261–267, 1996.[CrossRef][Web of Science][Medline]
12. Christensen AE, Selheim F, de Rooij J, Dremier S, Schwede F, Dao KK, Martinez A, Maenhaut C, Bos JL, Genieser HG, Doskeland SO. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 278: 35394–35402, 2003.
13. Dames P, Zimmermann B, Schmidt R, Rein J, Voss M, Schewe B, Walz B, Baumann O. cAMP regulates plasma membrane vacuolar-type H+-ATPase assembly and activity in blowfly salivary glands. Proc Natl Acad Sci USA 103: 3926–3931, 2006.
14. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474–477, 1998.[CrossRef][Medline]
15. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 901–906, 2002.[CrossRef][Web of Science][Medline]
16. Frokiaer J, Nielsen S, Knepper MA. Molecular physiology of renal aquaporins and sodium transporters: exciting approaches to understand regulation of renal water handling. J Am Soc Nephrol 16: 2827–2829, 2005.
17. Garcia F, Kierbel A, Larocca MC, Gradilone SA, Splinter P, LaRusso NF, Marinelli RA. The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP. J Biol Chem 276: 12147–12152, 2001.
18. Gekle M, Wunsch S, Oberleithner H, Silbernagl S. Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties. Pflügers Arch 428: 157–162, 1994.[CrossRef][Web of Science][Medline]
19. Glass DB, Lundquist LJ, Katz BM, Walsh DA. Protein kinase inhibitor-(6-22)-amide peptide analogs with standard and nonstandard amino acid substitutions for phenylalanine 10. Inhibition of cAMP-dependent protein kinase. J Biol Chem 264: 14579–14584, 1989.
20. Glunde K, Guggino SE, Solaiyappan M, Pathak AP, Ichikawa Y, Bhujwalla ZM. Extracellular acidification alters lysosomal trafficking in human breast cancer cells. Neoplasia 5: 533–545, 2003.[Web of Science][Medline]
21. Hays S, Kokko JP, Jacobson HR. Hormonal regulation of proton secretion in rabbit medullary collecting duct. J Clin Invest 78: 1279–1286, 1986.[Web of Science][Medline]
22. Hudson RL. Bafilomycin-sensitive acid secretion by mantle epithelium of the freshwater clam, Unio complanatus. Am J Physiol Regul Integr Comp Physiol 264: R946–R951, 1993.
23. Isnard-Bagnis C, Da Silva N, Beaulieu V, Yu AS, Brown D, Breton S. Detection of ClC-3 and ClC-5 in epididymal epithelium: immunofluorescence and RT-PCR after LCM. Am J Physiol Cell Physiol 284: C220–C232, 2003.
24. Kelada AS, Macaulay SL, Proietto J. Cyclic AMP acutely stimulates translocation of the major insulin-regulatable glucose transporter GLUT4. J Biol Chem 267: 7021–7025, 1992.
25. Keyes SR, Rudnick G. Coupling of transmembrane proton gradients to platelet serotonin transport. J Biol Chem 257: 1172–1176, 1982.
26. Kleizen B, Braakman I, de Jonge HR. Regulated trafficking of the CFTR chloride channel. Eur J Cell Biol 79: 544–556, 2000.[CrossRef][Web of Science][Medline]
27. Lambers TT, Oancea E, de Groot T, Topala CN, Hoenderop JG, Bindels RJ. Extracellular pH dynamically controls cell surface delivery of functional TRPV5 channels. Mol Cell Biol 27: 1486–1494, 2007.
28. Levine N, Kelly H. Measurement of pH in the rat epididymis in vivo. J Reprod Fertil 52: 333–335, 1978.
29. Levine N, Marsh DJ. Micropuncture studies of the electrochemical aspects of fluid and electrolyte transport in individual seminiferous tubules, the epididymis and the vas deferens in rats. J Physiol 213: 557–570, 1971.
30. Lu H, Sun TX, Bouley R, Blackburn K, McLaughlin M, Brown D. Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2. Am J Physiol Renal Physiol 286: F233–F243, 2004.
31. Myers M, Forgac M. The coated vesicle vacuolar (H+)-ATPase associates with and is phosphorylated by the 50-kDa polypeptide of the clathrin assembly protein AP-2. J Biol Chem 268: 9184–9186, 1993.
32. Noda Y, Sasaki S. Regulation of aquaporin-2 trafficking and its binding protein complex. Biochim Biophys Acta 1758: 1117–1125, 2006.[Medline]
33. Pastor-Soler N, Bagnis C, Sabolic I, Tyszkowski R, McKee M, Van Hoek A, Breton S, Brown D. Aquaporin 9 expression along the male reproductive tract. Biol Reprod 65: 384–393, 2001.
34. Pastor-Soler N, Beaulieu V, Litvin TN, Da Silva N, Chen Y, Brown D, Buck J, Levin LR, Breton S. Bicarbonate-regulated adenylyl cyclase (sAC) is a sensor that regulates pH-dependent V-ATPase recycling. J Biol Chem 278: 49523–49529, 2003.
35. Pastor-Soler N, Pietrement C, Breton S. Role of acid/base transporters in the male reproductive tract and potential consequences of their malfunction. Physiology Bethesda 20: 417–428, 2005.[CrossRef][Medline]
36. Pfister MF, Forgo J, Ziegler U, Biber J, Murer H. cAMP-dependent and -independent downregulation of type II Na-Pi cotransporters by PTH. Am J Physiol Renal Physiol 276: F720–F725, 1999.
37. Prat AG, Cunningham CC, Jackson GR Jr, Borkan SC, Wang Y, Ausiello DA, Cantiello HF. Actin filament organization is required for proper cAMP-dependent activation of CFTR. Am J Physiol Cell Physiol 277: C1160–C1169, 1999.
38. Seino S, Shibasaki T. PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. Physiol Rev 85: 1303–1342, 2005.
39. Shapiro M, Matthews J, Hecht G, Delp C, Madara JL. Stabilization of F-actin prevents cAMP-elicited Cl- secretion in T84 cells. J Clin Invest 87: 1903–1909, 1991.[Web of Science][Medline]
40. Steinmetz PR. Cellular organization of urinary acidification. Am J Physiol Renal Fluid Electrolyte Physiol 251: F173–F187, 1986.
41. Stevens AL, Breton S, Gustafson CE, Bouley R, Nelson RD, Kohan DE, Brown D. Aquaporin 2 is a vasopressin-independent, constitutive apical membrane protein in rat vas deferens. Am J Physiol Cell Physiol 278: C791–C802, 2000.
42. Sun-Wada GH, Wada Y, Futai M. Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: toward the physiological understanding of inside acidic compartments. Biochim Biophys Acta 1658: 106–114, 2004.[Medline]
43. Szaszi K, Kurashima K, Kaibuchi K, Grinstein S, Orlowski J. Role of the cytoskeleton in mediating cAMP-dependent protein kinase inhibition of the epithelial Na+/H+ exchanger NHE3. J Biol Chem 276: 40761–40768, 2001.
44. Voss M, Vitavska O, Walz B, Wieczorek H, Baumann O. Stimulus-induced phosphorylation of V-ATPase by protein kinase A. J Biol Chem 282: 33735–33742, 2007.
45. Wagner CA, Finberg KE, Breton S, Marshansky V, Brown D, Geibel JP. Renal vacuolar-ATPase. Physiol Rev 84: 1263–1314, 2004.
46. Wu MS, Bens M, Cluzeaud F, Vandewalle A. Role of F-actin in the activation of Na(+)-K(+)-Cl- cotransport by forskolin and vasopressin in mouse kidney cultured thick ascending limb cells. J Membr Biol 142: 323–336, 1994.[Web of Science][Medline]
47. Yip KP. Epac-mediated Ca2+ mobilization and exocytosis in inner medullary collecting duct. Am J Physiol Renal Physiol 291: F882–F890, 2006.
This article has been cited by other articles:
![]() |
W. Liu, Y. Wei, P. Sun, W.-H. Wang, T. R. Kleyman, and L. M. Satlin Mechanoregulation of BK channel activity in the mammalian cortical collecting duct: role of protein kinases A and C Am J Physiol Renal Physiol, October 1, 2009; 297(4): F904 - F915. [Abstract] [Full Text] [PDF] |
||||
![]() |
J D. King Jr., A. C. Fitch, J. K. Lee, J. E. McCane, D.-O. D. Mak, J. K. Foskett, and K. R. Hallows AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR Am J Physiol Cell Physiol, July 1, 2009; 297(1): C94 - C101. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. C. Shum, N. Da Silva, D. Brown, and S. Breton Regulation of luminal acidification in the male reproductive tract via cell-cell crosstalk J. Exp. Biol., June 1, 2009; 212(11): 1753 - 1761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Brown, T. G. Paunescu, S. Breton, and V. Marshansky Regulation of the V-ATPase in kidney epithelial cells: dual role in acid-base homeostasis and vesicle trafficking J. Exp. Biol., June 1, 2009; 212(11): 1762 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Hallows, R. Alzamora, H. Li, F. Gong, C. Smolak, D. Neumann, and N. M. Pastor-Soler AMP-activated protein kinase inhibits alkaline pH- and PKA-induced apical vacuolar H+-ATPase accumulation in epididymal clear cells Am J Physiol Cell Physiol, April 1, 2009; 296(4): C672 - C681. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Belleannee, N. D. Silva, W.W.C. Shum, M. Marsolais, R. Laprade, D. Brown, and S. Breton Segmental Expression of the Bradykinin Type 2 Receptor in Rat Efferent Ducts and Epididymis and Its Role in the Regulation of Aquaporin 9 Biol Reprod, January 1, 2009; 80(1): 134 - 143. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |